Warren Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen

In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.

from Stocks-Markets-Economic Times
Read The Rest:economictimes...